Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Determination Of Diagnostic Lab Test Payments Required Under HR 2768

This article was originally published in The Gray Sheet

Executive Summary

The Centers for Medicare & Medicaid Services would be directed to develop procedures for determining a basis and payment amounts for clinical diagnostic laboratory tests under an amendment to the "Medicare Regulatory and Contracting Relief Act" (HR 2768) adopted by the House Ways & Means Committee during an Oct. 11 mark-up.
Advertisement

Related Content

IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals
IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals
Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill
Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill
Advertisement
UsernamePublicRestriction

Register

MT015531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel